Pivotal Beta

Pivotal Life Sciences (formerly known as Nan Fung Life Sciences) is a global investment platform focused on the life sciences sector. The firm manages a multi-stage investment strategy, encompassing venture capital through its Pivotal bioVenture Partners funds, as well as public equity and direct company creation. Pivotal Life Sciences targets transformative therapeutics and healthcare technologies across North America, Europe, and China, with a particular emphasis on addressing major unmet medical needs in oncology, rare diseases, and chronic conditions. The entity 'Pivotal Beta' specifically refers to one of the firm's investment vehicles used to lead significant financing rounds for clinical-stage biotechnology companies.